Sun Pharmaceutical Acquires Organon for $11.75 Billion
Sun Pharmaceutical Industries Limited entered a merger agreement on April 26, 2026, to acquire Organon & Co. (OGN) in an all-cash deal valued at $11.75 billion. Deal Structure:…
Written byAsif SuriaSource: InsideArbitrage
Sun Pharmaceutical Industries Limited entered a merger agreement on April 26, 2026, to acquire Organon & Co. (OGN) in an all-cash deal valued at $11.75 billion. Deal Structure: Sun Pharma will acquire all outstanding shares of Organon for $14 per share, representing a 24.33% premium from the stock’s last close. Company Profile: Organon is a